Apoptosis in mesangial cells induced by ionizing radiation and cytotoxic drugs

Kidney International

Volumn 50, Issue 5, 1996, Pages 1565-1571

  Cha, Dae Ryong ^a   Feld, Stella M ^a   Nast, Cynthia ^a   Lapage, Janine ^a   Adler, Sharon G ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; MELPHALAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GLOMERULOPATHY; IONIZING RADIATION; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029961206     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.472     Document Type: Article

References (51)

1. STRIKER LJ, PETEN EP, ELLIOT SJ, DOI T, STRIKER GE: Biology of disease, Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 64:446-456, 1991
2. KASHGARIAN M, STERZEL RB: The pathobiology of the mesangium. Kidney Int 41:524-529, 1992
3. KERR JFR, WYLLIE AH, CURRIE AR: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972
4. RAFF MC: Social controls on cell survival and cell death. Nature 356:397-400, 1992
5. WYLLIE AH, KERR JFR, CURRIE AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
6. HARRISON DJ: Cell death in the diseased glomerulus. Histopathology 12:679-683, 1988
7. SAVILL J, SMITH J, SARRAF C, REN Y, ABBOTT F, REES AJ: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42:924-936, 1992
8. SAVILL J: Apoptosis: A mechanism for regulation of the cell complement of inflamed glomeruli. 41:607-612, 1992
9. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
10. BELL DA, MORRISON B: The spontaneous apoptotic death of normal human lymphocytes in vitro: The release of and immunoproliferative response to nucleosomes in vitro. Clin Immunol Immunopathol 60:13-26, 1991
11. CORITSIDIS G, BEERS P, PIZZUTO A, RUMORE P: Oligonucleosome binding to cultured rat mesangial cells and matrix: Evidence for receptor mediated binding. (abstract) J Am Soc Nephrol 4:598, 1993
12. WOO D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333:18-25, 1995
13. BARRY MA, BEHNKE CA, EASTMAN A: Activation of programmed cell death (Apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353-2362, 1990
14. BANSAL N, HOULE AG, MELNYKOVYCH G: Comparison of dexamethasone and lovastatin (mevinolin) as growth inhibitors in cultures of T cell derived human acute leukemia lines (CEM). Leukemia Res 13:875-882, 1989
15. ADLER SG, LACHANT NA, ANDERSON PS, COHEN AH, DAVIDSON WD, GLASSOCK RJ: Dimethyl sulfoxide enhances hexose monophosphate shunt activity in cultured glomerular mesangial cells, leukocytes, and erythrocytes. Miner Electrol Metab 17:52-57, 1991
16. ISHIZAKI M, SATO S, FUKADA J, SUGISAKI Y, MASUGI Y: The presence of Thy-1,1 antigen in rat glomerular mesangial cells. Biomed Res 1:438, 1980
17. LABARCA C, PAIGEN K: A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102:344-352, 1980
18. GAVRIELI Y, SHERMAN Y, SHMUEL A, SASSON B: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
19. SHIMIZU A, KITAMURA H, MASUDA Y, ISHIZAKI M, SUGISAKI Y, YAMANAKA N: Apoptosis (APO) in repair process of experimental mesangioproliferative glomerulonephritis (GN). (abstract) J Am Soc Nephrol 4:633, 1993
20. SUGIYAMA H, KASHIHARA N, YAMASAKI Y, SEKIKAWA T, OKAMOTO K, KANAO K, MAESHIMA Y, MAKINO H, OTA Z: Apoptosis of glomerular cells in human glomerular disease. (abstract) J Am Soc Nephrol 5:844, 1994
21. MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL J: Kinetic analysis of apoptosis in resolution of the rat Thy1.1 model of mesangial proliferative glomerulonephritis. (abstract) J Am Soc Nephrol 5:788, 1994
22. GERSCHENSON LE, ROTELLO RJ: Apoptosis: A different type of cell death. FASEB J 6:2450-2455, 1992
23. KERR JFR: Shrinkage necrosis: A distinct mode of cellular death. J Pathol 105:13-20, 1971
24. KERR JFR, SEARLE J: A suggested explanation for the paradoxically slow growth rate of basal cell carcinomas that contain numerous mitotic figures. J Pathol 107:41-44, 1972
25. ARENDS MJ, MORRIS RG, WYLLIE AH: Apoptosis: The role of the endonuclease. Am J Pathol 136:593-608, 1990
26. ALISON MR, SARRAF CE: Apoptosis: A gene directed programme of cell death. J Roy Coll Phys Lond 26:25-35, 1992
27. COHEN JJ: Programmed cell death in the immune system. Adv Immunol 50:55-85, 1991
28. SEN S, INCALCI MD: Apoptosis: Biochemical events and relevance to cancer chemotherapy. FEBS 307:122-127, 1992
29. COHEN J, DUKE RC: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992
30. ANSARI B, COATES PJ, GREENSTEIN BD, HALL PA: In situ end labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1-8, 1993
31. GOLD R, SCHMIED M, GIEGERICH G, BREITSCHOPF H, HARTUNG HP, TOYKA KV, LASSMANN H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71:219-225, 1994
32. UCKER DS: Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells. Nature 327:62-63, 1987
33. WYLLIE AH: Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556, 1980
34. WYLLIE AH, MORRIS RG: Hormone induced cell death: Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol 109:78-87, 1982
35. KAWABORI S, SODA K, PERDUE MH, BIENENSTOCK J: The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone. Lab Invest 64:224-233, 1991
36. GANOTE CE, SEABRA GR, NAYLER WG, JENNINGS RB: Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol 80:419-450, 1975
37. YUH YS, THOMPSON EB: Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM: Specific c-myc mRNA suppression by dexamethasone. J Biol Chem 264:10904-10910, 1989
38. POWER REF, MANI S, CODINA J, CONNEELY OM, MALLEY BW: Dopaminergic and ligand independent activation of steroid hormone receptors. Science 251:1636-1639, 1991
39. MCCONKEY DJ, NICOTERA P, HARTZELL P, BELLOMO G, WYLLIE AH, ORRENIUS S: Glucocorticoid activate a suicide process in thymocytes through an elevation of cytosolic calcium concentration. Arch Biochem Biophys 269:365-370, 1989
40. MOORE MJ: Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 20:194-208, 1991
41. YAZDANBAKHSH K, CHOI JW, LI Y, LAU CF, CHOI Y: Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc Natl Acad Sci USA 17:437-441, 1995
42. SAIAGH S, FABIEN N, AUGER C, MONIER JC: Induction of apoptosis in mouse thymocytes by cyclosporin A: In vivo study. Immunopharmacol Immunotoxicol 16:359-388, 1994
43. ZAMBETTI GP, LEVINE AJ: A comparison of the biological activities of wild type and mutant p53. FASEB J 7:855-865, 1993
44. MERCER WE, SHIELDS MT, LIN D, APPELLA E, ULLRICH SJ: Growth suppression induced by wild type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 88:1958-1962, 1991
45. FIELDS S, JANG SK: Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049, 1990
46. GINSBERG D, MECHTOR F, YANIV M, OREN M: Wild type p53 can down modulate the activity of various promotors. Proc Natl Acad Sci USA 88:9979-9983, 1991
47. DAVIDOFF AN, MENDELOW BV: Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide. Exp Hematol 21:922-927, 1993
48. WILLIAMS GT: Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097-1098, 1991
49. WILLIAMS GT, SMITH CA: Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74:777-779, 1993
50. CUADRADO SG, ORTIZ A, KARP S, CIZMAN SLB, ARMADA MJL, MADAIO M, EGIDO J, NEILSON EG: The Fas ligand (FasL) - Fas (CD95) system in the kidney, (abstract) J Am Soc Nephrol 5:748, 1994
51. UDA S, YOSHIMURA A, INUI K, SUGENOYA Y, NABESHIMA K, TAIRA T, IDEURA T: Glomerular expression of apoptosis related molecules in rats with mesangial proliferative nephritis. (abstract) J Am Soc Nephrol 5:797, 1994